{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:34:00Z","timestamp":1787762040844,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To prove the position of aripiprazole as a preventive and safe agent in delirium in patients admitted to the intensive care unit (ICU), it is necessary to conduct randomized controlled clinical trials with appropriate design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      In this study, 80 patients were randomly divided into two groups of 40. Group A received placebo mart for one week, and group B received 15 mg aripiprazole daily (dissolved in 10 cc) daily. As a criterion for assessing delirium, the Confusion Assessment methods for the ICU (CAM-ICUs) were evaluated daily for patients. At the end of the study, the trends of CAM-ICU and CAM-ICU changes on day 7 were compared between the two groups. All statistical tests were performed in two domains with a significance level of 5% using the\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test. Statistical Package for the Social Sciences (SPSS) 21 software was used to analyze the data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The use of aripiprazole in the studied indices was not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). The results related to the length of stay in the ICU, showed that although the use of aripiprazole has reduced the length of hospitalization of patients in the ICU, this rate of reduction, was not significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The use of aripiprazole with the approach of reducing the risk or controlling the occurrence of delirium on patients admitted to the intensive care unit, despite creating some beneficial effects such as reducing the length of hospital stay in the ICU, cannot be clearly and significantly effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_314_21","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T04:10:21Z","timestamp":1690431021000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Effect of Aripiprazole Supplementation in the Prevention of Delirium in Patients Admitted to the General Intensive Care Unit"],"prefix":"10.4103","volume":"12","author":[{"given":"Mehranoosh","family":"Nouri","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab","family":"Salimi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Anesthesiology Research Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Kosha","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Abtahi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7]]},"reference":[{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1001\/jama.2008.885","article-title":"Agitation and delirium at the end of life: \u201cWe couldn't manage him\u201d","volume":"300","author":"Breitbart","year":"2008","journal-title":"JAMA"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0749-0690(18)30089-2","article-title":"Delirium in hospitalized older patients","volume":"14","author":"Inouye","year":"1998","journal-title":"Clin Geriatr Med"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12028-011-9520-0","article-title":"Delirium and sedation in the ICU","volume":"14","author":"Frontera","year":"2011","journal-title":"Neurocrit Care"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0033-3182(04)70170-X","article-title":"A double-blind trial of risperidone and haloperidol for the treatment of delirium","volume":"45","author":"Han","year":"2004","journal-title":"Psychosomatics"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4088\/JCP.v68n0102","article-title":"Antipsychotics in the treatment of delirium: A systematic review","volume":"68","author":"Seitz","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpsychores.2011.01.019","article-title":"Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium","volume":"71","author":"Grover","year":"2011","journal-title":"J Psychosom Res"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"923","DOI":"10.4088\/JCP.v62n1201","article-title":"Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: Illustrating their mechanism of action","volume":"62","author":"Stahl","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2005.02.051","article-title":"Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic","volume":"515","author":"Tadori","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"5 Suppl","key":"R12-20240830","first-page":"1","article-title":"Practice guideline for the treatment of patients with delirium","volume":"156","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2190\/33JH-KTV4-BE2W-AW05","article-title":"Aripiprazole in the treatment of delirium","volume":"35","author":"Alao","year":"2005","journal-title":"Int J Psychiatry Med"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc7714","article-title":"Routine delirium monitoring in a UK critical care unit","volume":"13","author":"Page","year":"2009","journal-title":"Crit Care"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000322883","article-title":"Anticholinergic drugs and their effects on delirium and mortality in the elderly","volume":"1","author":"Luukkanen","year":"2011","journal-title":"Dement GeriatrCogn Dis Extra"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1532-5415.2010.02762.x","article-title":"Delirium: An independent predictor of functional decline after cardiac surgery","volume":"58","author":"Rudolph","year":"2010","journal-title":"J Am SocGeriatr"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1540-8191.2005.00134.x","article-title":"Delirium in the postoperative cardiac patient: A review","volume":"20","author":"Sockalingam","year":"2005","journal-title":"J Card Surg"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10401230600948506","article-title":"Aripiprazole and delirium","volume":"18","author":"Alao","year":"2006","journal-title":"Ann Clin Psychiatry"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1176\/appi.psy.47.5.385","article-title":"Aripiprazole in the treatment of delirium","volume":"47","author":"Straker","year":"2006","journal-title":"Psychosomatics"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S1478951511000368","article-title":"An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients","volume":"9","author":"Boettger","year":"2011","journal-title":"Palliat Support Care"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/00048674.2011.543411","article-title":"Aripiprazole and haloperidol in the treatment of delirium","volume":"45","author":"Boettger","year":"2011","journal-title":"Aust NZJ Psychiatry"},{"key":"R22-20240830","first-page":"1363","article-title":"[Efficacy and safety of aripiprazole for delirium in emergency medical care center\u2013a retrospective study of 41 patients treated by antipsychotics]","volume":"14","author":"Kato","year":"2011","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00228-019-02802-1","article-title":"Aripiprazole for prevention of delirium in the neurosurgical intensive care unit: A double-blind, randomized, placebo-controlled study","volume":"76","author":"Mokhtari","year":"2020","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_314_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:16:22Z","timestamp":1787760982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_314_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_314_21","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2021-10-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}